Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

2.9K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

677
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
677
Cancer Therapies02:49

Cancer Therapies

8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
The Tumor Microenvironment02:17

The Tumor Microenvironment

6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Cancer Vaccines01:30

Cancer Vaccines

523
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
523

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Meta-amplified dark-field interferometric scattering microscopy.

Nature communications·2026
Same author

Mode-Specific Coherent Interference of Vibrational Sum-Frequency Generation Imaging: An Approach to Differentiate Lung Tumors through Collagen Interfibrillar Distances.

Journal of the American Chemical Society·2025
Same author

Breast cancer cell-secreted miR-199b-5p hijacks neurometabolic coupling to promote brain metastasis.

Nature communications·2024
Same author

Colocalization of protein and microRNA markers reveals unique extracellular vesicle subpopulations for early cancer detection.

Science advances·2024
Same author

Lung Fibroblasts Take up Breast Cancer Cell-derived Extracellular Vesicles Partially Through MEK2-dependent Macropinocytosis.

Cancer research communications·2024
Same author

Cancer-cell-secreted extracellular vesicles target p53 to impair mitochondrial function in muscle.

EMBO reports·2023

Related Experiment Video

Updated: Sep 20, 2025

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

2.7K

Extracellular vesicles in cancer therapy.

Shizhen Emily Wang1

  • 1Department of Pathology, University of California, San Diego, CA 92093, USA.

Seminars in Cancer Biology
|June 10, 2022
PubMed
Summary

Extracellular vesicles (EVs) are key in cell communication and cancer progression. Targeting EVs offers new therapeutic strategies and diagnostic biomarkers for cancer care.

Keywords:
Anticancer vaccinesCancer therapyDrug delivery vehiclesExosomesExtracellular vesiclesMetastasisPremetastatic nicheTumor microenvironment

More Related Videos

LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles
12:18

LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles

Published on: February 1, 2020

5.9K
An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue
10:33

An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue

Published on: February 3, 2023

1.4K

Related Experiment Videos

Last Updated: Sep 20, 2025

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

2.7K
LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles
12:18

LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles

Published on: February 1, 2020

5.9K
An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue
10:33

An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue

Published on: February 3, 2023

1.4K

Area of Science:

  • Cell Biology
  • Oncology
  • Biotechnology

Background:

  • Extracellular vesicles (EVs) are crucial mediators of intercellular communication.
  • Tumor-derived EVs play significant roles in cancer progression, including therapy resistance and metastasis.
  • EVs carry cargo reflecting their cell of origin, making them potential biomarker sources.

Purpose of the Study:

  • To highlight recent advancements in translating Extracellular vesicle (EV) research into cancer care.
  • To discuss the development of non-invasive EV-based biomarkers for cancer diagnosis and monitoring.
  • To review therapeutic strategies involving tumor-derived EVs and engineered EVs.

Main Methods:

  • Review of recent scientific literature on Extracellular vesicles (EVs) in cancer.
  • Analysis of advancements in EV-based biomarker development.
  • Evaluation of therapeutic applications targeting or utilizing EVs.

Main Results:

  • Extracellular vesicles (EVs) are implicated in various aspects of cancer, including tumor microenvironment modulation and immune evasion.
  • EV-based biomarkers show promise for early cancer detection and treatment response prediction.
  • Targeting tumor-derived EVs and engineering therapeutic EVs are emerging cancer treatment strategies.

Conclusions:

  • Extracellular vesicle (EV) research is rapidly advancing towards clinical applications in oncology.
  • EVs offer novel avenues for non-invasive cancer diagnostics and targeted therapeutics.
  • Harnessing EVs presents a promising frontier for improving cancer patient outcomes.